News

Three new JAK inhibitor medications have hit the market in recent years to treat alopecia. While they don't cure it, they are ...
Adults with atopic dermatitis treated with upadacitinib had fewer major adverse cardiovascular events compared with ...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today ...
Dr Ray O’Connor takes a look at the latest clinical articles on rheumatoid arthritis – and how its management has been so ...
There have been important recent advances in the management of Crohn's disease, including new classes of biological or small molecule therapies, an appreciation that endoscopic mucosal healing results ...
The use of high-dose methotrexate (HD-MTX) has improved survival rates. This article describes the experience of a patient treated with HD-MTX and outlines the essential aspects of care for the ...
Secondary metabolism consists of metabolic pathways and products of metabolism that are not absolutely required for the survival of the plant. Secondary metabolism is responsible for many ...